Pharmaceuticals & Therapeutics

A new journal issue reveals how venture capital, advanced clinical insights, and patient-centered drug design are creating a new era in heart failure care.

A clinical trial for D-Serine begins in Norway, testing a novel approach that could finally slow or halt the progression of Parkinson's disease.

A new partnership integrates advanced imaging and ablation tech, aiming to revolutionize pain treatment as procedures shift from hospitals to clinics.

Canadian giant Aurora Cannabis gains exclusive EU rights for two key strains, signaling a new era of genetic ownership in Europe's booming medical market.

As CRNA Week begins, a closer look reveals these highly trained nurses are essential for rural access, patient safety, and healthcare system stability.

Carrying the Alzheimer's gene, a longevity expert has turned himself into a public experiment, documenting his radical protocol to prevent the disease.

Australian biopharma Immuron reports strong global sales for its travel supplement and launches a new IBS product, navigating industry mergers and digital trends.

Shanghai's premier electronics expo sets the stage for a new manufacturing era, showcasing embodied AI, new energy vehicles, and revolutionary medical tech.

Genmab's antibody drug epcoritamab is the first of its kind to slow cancer progression in a Phase 3 trial for R/R DLBCL, offering a new path for patients.

South Korean researchers created a 'Janus' patch that bonds to wet tissue in seconds, preventing dangerous leaks and complications in neurosurgery.

A first-in-class immunotherapy, UNLOXCYT™, offers a new lifeline for patients with advanced skin cancer, made accessible through a key national partnership.

The deal combines Apollo Care's tech platform with eStrat's copay expertise, aiming to streamline drug access and boost pharma's bottom line.

A landmark Nature Medicine publication for OrsoBio's TLC-2716 offers new hope for millions suffering from severe lipid and liver disorders.

In a strategic move to enhance domestic drug production, Agno Pharma has acquired a key Oregon manufacturing site, signaling major industry consolidation.

The pet nutrition giant previews a breakthrough feline diabetes diet, home care kits, and a fresh food line, signaling a strategic shift in pet healthcare.

With a new $16.5M loan, Ocular Science is poised to expand its role in compounded eye medications, meeting the needs of an aging population.

Backed by Canada's life sciences engine adMare, new biotech firm Ocythera is advancing a unique non-retinoid therapy for debilitating bone disorders.

The beauty industry is surging, but the focus is shifting from superficial glamour to inner wellness. Discover the rise of ingestible supplements.

New England Donor Services celebrates a record year with innovative tech, but looming federal policy changes threaten the entire organ donation system.

InterAx's AI platform and Alveus's R&D expertise combine in a new partnership to develop a next-gen obesity drug with durable results and better tolerability.